BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| BAY-876 | BAY-876 is a potent and selective inhibitor of GLUT1, which is overexpressed in multiple cancers. Uses: Anticancer agent. Group: Pharmaceutical. CAS No. 1799753-84-6. Pack Sizes: 100 mg. Product ID: B0084-053992. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| BAY-985 | BAY-985 is a highly effective, orally active and selective TANK-binding kinase 1 (TBK1) and IκB kinase ε dual inhibitor, with anti-tumor activity. Group: Pharmaceutical. CAS No. 2409479-29-2. Pack Sizes: 100 mg. Product ID: B1370-373113. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (±)-Bay K 8644 | (±)-Bay K 8644 is a L-type Ca2+ channel activator. It exhibits positive inotropic, vasoconstrictive and behavioral effects in vivo. Uses: Reprogramming. Group: Pharmaceutical. CAS No. 71145-03-4. Pack Sizes: 25 mg. Product ID: B2693-462890. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bayogenin 3-O-β-D-glucopyranoside | Bayogenin 3-O-β-D-glucopyranoside is a triterpenoid saponin isolated from the aerial parts of Polygala japonica Houtt. Group: Pharmaceutical. CAS No. 104513-86-2. Pack Sizes: 5 mg. Product ID: B0005-053787. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bazedoxifene acetate | Bazedoxifene acetate, also called as TSE424 or WAY-140424, is a selective nonsteroidal estrogen receptor modulator (SERM) with antiosteoporotic activity (ERα: IC50= 26 nM; ERβ= 99 nM). Uses: Bone density conservation agents. Group: Pharmaceutical. CAS No. 198481-33-3. Pack Sizes: 1 g. Product ID: B2693-206133. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bazedoxifene Impurities | Bazedoxifene Impurities, intricately arising as trace chemical constituents during bazedoxifene synthesis, hold critical importance in purity validation and therapeutic efficacy assessment. These impurities, pivotal in ensuring osteoporotic treatment reliability, particularly aid in reducing fracture risks among postmenopausal women, thus reinforcing the compound's clinical application. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BCN-OH | BCN-OH is an alcohol functionalized cyclooctyne derivative. Group: Pharmaceutical. CAS No. 1263166-90-0. Pack Sizes: 1 g. Product ID: BB054510. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BCN-PEG4-NHS ester | BCN-endo-PEG4-NHS is an ADC Linker containing 4 PEG units. Group: Pharmaceutical. CAS No. 1702356-19-1. Pack Sizes: 50 mg. Product ID: BADC-00415. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BD 1047 dihydrobromide | The dihydrobromide salt form of BD-1047, a selective σ1 receptor antagonist, has been found to have antipsychotic effect and could be probably used against schizophrenia and neuropathic pain. Uses: Bd 1047 dihydrobromide is a selective antagonist of σ receptors. Group: Pharmaceutical. CAS No. 138356-21-5. Pack Sizes: 1 g. Product ID: B1370-361794. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BD140 [for Albumin binding assay] | BD140 [for Albumin binding assay]. Group: Pharmaceutical. CAS No. 1201643-08-4. Pack Sizes: 100 mg. Product ID: F01-0255. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BDA-366 | BDA-366 is a small-molecule antagonist of Bcl2-BH4 domain with high affinity and selectivity for Bcl2-BH4. BDA-366 induces apoptosis in multiple myeloma cells via Bcl2 conformational change. Group: Pharmaceutical. CAS No. 1909226-00-1. Pack Sizes: 300 mg. Product ID: B0084-053991. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BDY FL, SE | BODIPY dyes are used to generate fluorescent conjugates of proteins, nucleotides, oligonucleotides and dextrans, as well as to prepare fluorescent enzyme substrates, fatty acids, phospholipids, lipopolysaccharides, receptor ligands and polystyrene microspheres. Group: Pharmaceutical. CAS No. 146616-66-2. Pack Sizes: 50 mg. Product ID: B0245-118888. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BEC HCl | BEC HCl is an Arginase II inhibitor(Ki=0.31μM).In vitro,BEC HCl enhances NO-dependent smooth muscle relaxation by binding to arginase as a transition state analogue.In vivo,BEC HCl enhances peribronchiolar and perivascular inflammation in mice. Group: Pharmaceutical. CAS No. 222638-67-7. Pack Sizes: 25 mg. Product ID: B0084-245384. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Beclomethasone Impurities | Beclomethasone Impurities are crucial components within pharmaceutical quality control, facilitating the detection and measurement of contaminants in beclomethasone-based pharmaceuticals. These impurities play a critical role in verifying the purity and safety of medications for conditions like asthma and allergic rhinitis, ultimately augmenting therapeutic efficacy and safeguarding patient well-being. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bedaquiline | TMC207 is a first-in-class diarylquinoline compound with a novel mechanism of action, the inhibition of bacterial ATP synthase, and potent activity against drug-sensitive and drug-resistant TB. Group: Pharmaceutical. CAS No. 843663-66-1. Pack Sizes: 100 mg. Product ID: B0084-152490. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bedaquiline fumarate | Bedaquiline fumarate is an anti-tuberculosis drug which selectively inhibits the mycobacterial energy metabolism and found to be effective against all states of Mycobacterium tuberculosis. It possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase. It has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis, however, its side effect profile limits its use against MDR-TB when no other effective regimen can be provided. Uses: Antitubercular agents. Group: Pharmaceutical. CAS No. 845533-86-0. Pack Sizes: 200 mg. Product ID: B0084-463644. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Belinostat | Belinostat is a hydroxamic acid-type histone deacetylase (HDAC) inhibitor. Belinostat targets HDAC enzymes to inhibit tumor cell proliferation and angiogenesis, induce apoptosis and promote cellular differentiation. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 414864-00-9. Pack Sizes: 100 mg. Product ID: B0084-141764. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Belinostat impurities | Belinostat impurities are crucial components in the development and quality control of the HDAC inhibitor, Belinostat, utilized in treating peripheral T-cell lymphoma. These impurities help ensure drug efficacy and safety, supporting ongoing research in cancer therapy by identifying and analyzing degradation products and potential interactions within the body. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bellidifolin | Bellidifolin is a xanthone that can be isolated from the plants of Gentiana species. Study shows that bellidifolin is a potent hypoglycemic agent in streptozotocin (STZ)-induced diabetic rats from Swertia japonica. Bellidifolin may contribute to the protective effects associated with nerve injury initiated by hypoxia by mechanisms related to inhibition of cell apoptosis independent of the ERK pathway, but may involve blockade of p38MAPK signaling pathway activation and downstream caspase-3 expression. Group: Pharmaceutical. CAS No. 2798-25-6. Pack Sizes: 5 mg. Product ID: NP7359. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Belnacasan | Belnacasan is a potent and selective inhibitor of caspase-1 with Ki of 0.8 nM. Belnacasan inhibits interlukin-1β biosynthesis. Group: Pharmaceutical. CAS No. 273404-37-8. Pack Sizes: 50 mg. Product ID: B0084-307700. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Beloranib Impurities | Beloranib Impurities serve as fundamental contributors to biomedical research progress, instrumental in refining Beloranib, a therapeutic targeting obesity-linked afflictions and Prader-Willi syndrome. Their critical role in drug safety and efficacy underscores their utility in identifying and analyzing manufacturing byproducts, thereby enhancing pharmaceutical dependability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bemcentinib | Bemcentinib is a selective small molecule inhibitor of Axl kinase, which showed activity to blocks tumor spread and prolongs survival in models of metastatic breast cancer. The receptor tyrosine kinase Axl may play an important role in cancer progression, invasion, metastasis, drug resistance, and patient mortality. R428 inhibits Axl with low nanomolar activity and blocked Axl-dependent events, including Akt phosphorylation, breast cancer cell invasion, and proinflammatory cytokine production. Pharmacologic investigations revealed favorable exposure after oral administration such that R428-treated tumors displayed a dose-dependent reduction in expression of the cytokine granulocyte macrophage colony-stimulating factor and the epithelial-mesenchymal transition transcriptional regulator Snail. In support of an earlier study, R428 inhibited angiogenesis in corneal micropocket and tumor models. R428 administration reduced metastatic burden and extended survival in MDA-MB-231 intracardiac and 4T1 orthotopic (median survival, >80 days compared with 52 days; P < 0.05) mouse models of breast cancer metastasis. Additionally, R428 synergized with cisplatin to enhance suppression of liver micrometastasis. Our results show that Axl signaling regulates breast cancer metastasis at multiple levels in tumor cells and tumor stromal cells and that selective Axl blockade confers therapeutic value in prolonging survival of animals bearing metast | London |
| Bempedoic Acid Impurities | Bempedoic Acid Impurities are vital components for the analytical evaluation and quality control of the cholesterol-lowering drug, bempedoic acid. This compound is crucial for research on the drug's mechanism in reducing cardiovascular diseases by inhibiting ATP-citrate lyase, potentially helping to discover new therapeutic applications and optimization techniques. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benazepril Impurities | Benazepril Impurities are crucial in the biomedical industry for evaluating the purity and quality of Benazepril, an antihypertensive medication. These impurities are used in research and development to enhance drug safety, efficacy, and formulation by ensuring compliance with pharmaceutical standards and detecting potential toxicological risks. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bendamustine Chloro Dimer Impurity | Bendamustine Chloro Dimer Impurity is an impurity of Bendamustine, a chemotherapy medication indicated for the treatment of chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin's lymphoma. Group: Pharmaceutical. CAS No. 1228551-91-4. Pack Sizes: 10 mg. Product ID: B2694-467289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bendamustine hydrochloride | Bendamustine hydrochloride is the hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown, this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. Bendamustine may differ from other alkylators in that it may be more potent in activating p53-dependent stress pathways and inducing apoptosis; it may induce mitotic catastrophe; and it may activate a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Group: Pharmaceutical. CAS No. 3543-75-7. Pack Sizes: 500 mg. Product ID: NP3323. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bendamustine Hydrochloride Impurities | Bendamustine Hydrochloride Impurities are analyzed in the biomedical field to ensure drug purity and efficacy in cancer treatment, specifically for hematological malignancies like chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Their identification aids in refining cancer therapeutics and enhancing quality control in pharmaceutical production. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bendroflumethiazide-[d5] | Bendroflumethiazide-[d5] is a labelled Bendroflumethiazide. Bendroflumethiazide is a diuretic used to treat hypertension. Group: Pharmaceutical. CAS No. 1330183-13-5. Pack Sizes: 10 mg. Product ID: BLP-013872. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bendroflumethiazide Impurities | Bendroflumethiazide Impurities, integral to biomedical scrutiny, underpin rigorous quality control and nuanced safety evaluations of the diuretic bendroflumethiazide. Such meticulous impurity analyses are vital for the drug's role in hypertension and edema therapy, ensuring its efficacy, safety, and regulatory alignment, thereby fortifying patient health protection. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benidipine hydrochloride | Benidipine hydrochloride is the hydrochloride salt form of Benidipine, which is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). Group: Pharmaceutical. CAS No. 91599-74-5. Pack Sizes: 500 mg. Product ID: B2693-079515. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benidipine Impurities | Benidipine Impurities occupy a vital position in the realm of quality assurance and pharmaceutical innovation concerning cardiovascular therapeutics. Their significance lies in verifying the efficacy and safety of benidipine, a key calcium channel blocker for hypertension and angina, thereby refining manufacturing protocols by detecting potential degradation phenomena. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzamide Impurities | Benzamide impurities are pivotal in the pharmaceutical industry as analytical standards, ensuring the purity and efficacy of benzamide-based drugs. These impurities are crucial in the development and quality control of medications for psychiatric disorders, such as schizophrenia and bipolar disorder, enhancing overall drug safety and effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzamide, N-[4-methyl-3-[[4-(6-methyl-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]- | This product is a kinase inhibitor used in the treatment of certain types of cancer, including non-small cell lung cancer and pancreatic cancer. It works by inhibiting specific enzymes involved in cell growth and proliferation, ultimately leading to tumor regression. Group: Pharmaceutical. CAS No. 1032314-85-4. Pack Sizes: 10 mg. Product ID: B2699-456548. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzamil | Benzamil is a Na+/Ca2+ exchanger (NCX) inhibitor and epithelial sodium channel (ENaC) blocker. Benzamil has been developed as a promising treatment for cystic fibrosis. Group: Pharmaceutical. CAS No. 2898-76-2. Pack Sizes: 50 mg. Product ID: B2693-070965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzamil hydrochloride | Benzamil hydrochloride is a Na+/Ca2+ exhanger (NCX) inhibitor (IC50 ~ 100 nM) and an epithelial sodium channel (ENaC) blocker. Benzamil is an analogue of amiloride, and it is potentially used for the treatment of cystic fibrosis. Uses: Potential treatment of cystic fibrosis. Group: Pharmaceutical. CAS No. 161804-20-2. Pack Sizes: 50 mg. Product ID: B2693-312064. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzbromarone Impurities | Benzbromarone Impurities, manifesting as ancillary chemical artifacts in Benzbromarone synthesis, hold crucial significance in the evaluation of pharmacological quality and safety for hyperuricemia interventions. Their scrutiny is foundational for the progression and regulatory affirmation of Benzbromarone, a gout therapeutic agent enhancing uric acid elimination, thus ensuring superior pharmacodynamic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (Benzene-1,3,5-triyl)triacetonitrile | (Benzene-1,3,5-triyl)triacetonitrile (CAS# 80935-59-7 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 80935-59-7. Pack Sizes: 500 mg. Product ID: BB042404. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzenesulfonate Impurities | Benzenesulfonate Impurities, primarily seen in pharmaceutical analyses, are significant due to their potential impacts on drug safety profiles. Understanding these impurities aids in the meticulous assessment of antibiotics and antihypertensives, ensuring their purity and efficacy, thereby supporting the development of cleaner pharmaceutical products. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzethonium Impurities | Benzethonium Impurities, identified in pharmaceutical research, play a critical role in the study of benzethonium chloride's safety and efficacy margins. Understanding these impurities aids in the optimization of antimicrobial formulations, ensuring therapeutic applications while minimizing potential adverse effects. They are integral to quality control investigations in drug development processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzetimide hydrochloride | Benzetimide hydrochloride is a muscarinic acetylcholine receptor antagonist that has anticholinergic properties and could block pilocarpine-induced lacrimation. Uses: Amuscarinic acetylcholine receptor antagonist. Group: Pharmaceutical. CAS No. 5633-14-7. Pack Sizes: 500 mg. Product ID: B0084-125722. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzhexol Impurities | Benzhexol Impurities hold pivotal importance in the biomedical sector, facilitating rigorous quality assurance and pharmacokinetic assessments of anticholinergic drugs, such as trihexyphenidyl. These impurities are integral to ensuring the efficacy and safety of treatments for Parkinsons and extrapyramidal disorders, optimizing therapeutic strategies and elevating patient care standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzhydrazide Impurities | Benzhydrazide Impurities are critical in the biomedical industry for analyzing and ensuring drug purity and safety, particularly in the synthesis of antitubercular and antihypertensive medications. These impurities serve as reference standards, playing a pivotal role in quality control during pharmaceutical manufacturing and regulatory compliance processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benznidazole Impurities | Benznidazole impurities, fundamental constituents in quality assurance and pharmacological research, are integral in the therapeutic management of Chagas disease. These impurities aid in evaluating benznidazole's purity and stability, thus ensuring its efficacy against Trypanosoma cruzi, the causative parasite of Chagas disease, confirming their role in maintaining drug potency. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzocaine Impurities | Benzocaine Impurities, integral to the biomedical industry, are utilized in the quality control and testing of benzocaine formulations. These impurities help identify and quantify potential contaminants, ensuring the safety and efficacy of benzocaine, a common local anesthetic used to alleviate pain and discomfort in various medical procedures. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzofuran Impurities | Benzofuran impurities play a crucial role in the quality assessment and validation of pharmaceuticals targeting central nervous system disorders and cardiovascular diseases. They assist in the refinement of synthesis processes and ensure the efficacy and safety of benzofuran-based drugs, pivotal in neuroprotection and modulation of cardiac function. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzo[ghi]perylene | Benzo[ghi]perylene is an environmental pollutant. Uses: An n-channel organic semiconductor. Group: Pharmaceutical. CAS No. 191-24-2. Pack Sizes: 500 mg. Product ID: B0001-001583. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoic acid, 2-(3-methyl-1-oxobutyl)- | Benzoic acid, 2-(3-methyl-1-oxobutyl)- is an impurity of Butylphthalide, an anti-cerebral-ischemia drug. Group: Pharmaceutical. CAS No. 152567-80-1. Pack Sizes: 100 mg. Product ID: B0047-284884. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoin Impurities | Benzoin Impurities, frequently encountered in pharmaceutical preparations, play a crucial role in the biomedical industry by influencing drug purity and efficacy. These impurities serve as critical markers in quality control for anti-inflammatory and analgesic medications, ensuring the safety and therapeutic effectiveness of the final pharmaceutical product. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzophenone Impurities | Benzophenone Impurities play a crucial role in the pharmaceutical analysis of benzophenone derivatives used to treat disorders like anxiety and insomnia. These impurities are essential for ensuring the safety and efficacy of benzophenone-related formulations, facilitating rigorous quality control measures, and enhancing pharmacological research and development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzopyrene Impurities | Benzopyrene Impurities, widely studied in biomedical research, are critical for investigating carcinogenic processes and drug safety evaluations. These impurities are key factors in understanding the metabolic pathways related to polycyclic aromatic hydrocarbons, which are implicated in various cancers, thereby aiding the development of targeted cancer therapies and screening methodologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoquine Impurities | Benzoquine Impurities, integral to pharmaceutical sciences, play a crucial role in the development and characterization of quinone-based therapeutics. By facilitating the evaluation of safety and efficacy, particularly in oncological and cardiovascular treatments, they ensure drug purity while elucidating potential metabolic byproducts, thus enhancing therapeutic safety and effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzovindiflupyr Impurities | Benzovindiflupyr Impurities are analysed in the biomedical sector to ensure the safety and efficacy of Benzovindiflupyr-based treatments. These impurities are crucial for assessing potential adverse effects and developing enhanced antifungal agents for agricultural applications, indirectly impacting human health by ensuring safe crop protection solutions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoylaconine | Benzoylaconine is an alkaloid in the Chinese traditional medicine Radix Aconiti Lateralis Preparata. Group: Pharmaceutical. CAS No. 466-24-0. Pack Sizes: 20 mg. Product ID: NP0576. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoylhypacoitine | Benzoylhypacoitine is extracted from the roots of Aconitum carmichaeli Debx. It might be the principal active components which affect mitochondrial growth by Fuzi and its processed products. Uses: Might be the principal active components which affect mitochondrial growth by fuzi and its processed products. Group: Pharmaceutical. CAS No. 63238-66-4. Pack Sizes: 20 mg. Product ID: B0005-464498. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoylmesaconine | Benzoylmesaconine is the most abundant component of Wutou decoction, which is widely used in China because of its therapeutic effect on rheumatoid arthritis. Group: Pharmaceutical. CAS No. 63238-67-5. Pack Sizes: 20 mg. Product ID: B0005-464497. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzoylmesaconine-7-Palmitate | Benzoylmesaconine-7-Palmitate is an alkaloid isolated from aconitum carmichaeli Debx. Benzoylmesaconine has powerful antinociceptive, antiarrhythmic and properties due to their ability to blockade voltage-dependent sodium channels, but has less toxic monoesters than aconitine and mesaconitine. Group: Pharmaceutical. Pack Sizes: 20 mg. Product ID: B0005-479887. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzthiazuron-[d3] | Benzthiazuron-[d3] is a deuterium labelled Benzthiazuron, an herbicide used to control annual broad-leaved weeds in a variety of crops. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-014111. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benztropine Impurities | Benztropine Impurities are critical reference materials in drug development, primarily for the treatment of Parkinson's disease and drug-induced extrapyramidal symptoms. Understanding these impurities helps in ensuring the safety and efficacy of benztropine mesylate formulations, thereby aiding in quality control and regulatory compliance within pharmacological contexts. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzydamine Impurities | Benzydamine Impurities are indispensable in the biomedical realm, serving a crucial function in affirming the purity and safety of benzydamine, a non-steroidal anti-inflammatory agent. The analytical assessment of these impurities is pivotal in quality control, ensuring optimal pharmaceutical formulations for managing inflammatory disorders and pain-associated conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzyl 2,3,4-Tri-O-benzyl-α-D-glucopyranoside | Benzyl 2,3,4-Tri-O-benzyl-α-D-glucopyranoside, a widely employed compound within the biomedical sector, showcases a plethora of pharmacological attributes, rendering it efficacious in addressing select illnesses. Researchers fervently investigate this exceptional specimen's capacity to engender curative medications targeting distinct pathways linked to metabolic infirmities and contagions. Group: Pharmaceutical. CAS No. 59935-49-8. Pack Sizes: 1 g. Product ID: B2705-334393. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzyl 3,5-bis(phenylmethoxy)benzoate | An impurity of Terbutaline, which is a β-Adrenergic receptor agonist and could be used as a bronchodilator agent. Group: Pharmaceutical. CAS No. 50513-72-9. Pack Sizes: 100 mg. Product ID: B1712-284936. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzyl 4-(chlorocarbonyl)piperidine-1-carboxylate | Benzyl 4-(chlorocarbonyl)piperidine-1-carboxylate. Group: Pharmaceutical. CAS No. 10314-99-5. Pack Sizes: 5 g. Product ID: B1370-046701. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzyl (4-hydroxyphenyl)carbamate | Benzyl (4-hydroxyphenyl)carbamate, a crucial pharmaceutical intermediate, synergizes diverse drug synthesis. Capable of potentiating anti-neoplastic responses in conjunction with antioxidant activities, this molecular entity encapsulates immense therapeutic potential. Notably, investigations are underway to examine its efficacy as a prospective therapeutic agent for neurodegenerative conditions including Alzheimer's and Parkinson's diseases. Group: Pharmaceutical. CAS No. 7107-59-7. Pack Sizes: 1 g. Product ID: B2699-335083. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Benzyl nicotinate | Benzyl nicotinate is a metabolite of Nicotine, which is a potent parasympathomimetic stimulant. Group: Pharmaceutical. CAS No. 94-44-0. Pack Sizes: 1 kg. Product ID: NP2761. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bepotastine Besilate Impurities | Bepotastine Besilate Impurities, integral to pharmaceutical quality assurance, are scrutinized meticulously to uphold safety and efficacious standards, particularly within antihistaminic formulations. These impurities, meticulously analyzed, ensure the purity of Bepotastine, pivotal in combating allergic conjunctivitis, thereby fortifying the robustness of drug quality control measures. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bepotastine Besylate | Bepotastine is a histamine H1 receptor antagonist. Bepotastine has been approved in Japan for the treatment of allergic rhinitis and uriticaria/puritus. Group: Pharmaceutical. CAS No. 190786-44-8. Pack Sizes: 500 mg. Product ID: B0084-061917. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Beraprost sodium salt | Beraprost is an analog of prostacyclin in which the unstable enol-ether has been replaced by a benzofuran ether function. It inhibits platelet aggregation in healthy subjects and in diabetic patients at similar doses. Group: Pharmaceutical. CAS No. 88475-69-8. Pack Sizes: 5 mg. Product ID: B0084-467416. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Berbamine Hydrochloride | Berbamine is a calcium channel blocker which is isolated from the roots of Cocculus orbiculatus (L.) DC. It can block the calcium-induced contraction of depolarized pig coronary artery strips. It was indicated that Berbamine hydrochloride may competitively antagonize the action of calcium. Group: Pharmaceutical. CAS No. 6078-17-7. Pack Sizes: 5 g. Product ID: B2703-346013. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Berberine hydrochloride | Berberine hydrochloride is an isoqinoline alkaloid and acts as a COX-2 inhibitor that exhibits chemopreventive activity against colon tumor formation. Study in humans and hamsters shows that berberine reduces total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides. It also inhibits c-Jun and suppresses inflammation and cancers. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 633-65-8. Pack Sizes: 250 g. Product ID: B0084-073975. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Berberine Impurities | Berberine Impurities, integral to berberine formulations, are scrutinized for their impact on the efficacy and safety of treatments in cardiovascular and metabolic contexts. Their presence can modulate therapeutic outcomes in managing hypertension and type 2 diabetes, thereby serving a crucial function in pharmaceutical quality control and development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.